A biomarker panel consisting of HMMR, NXPH4, PITX1 and THBS4 was defined and validated as an effective serologic diagnostic tool for the detection of HCC patients among liver disease patients through the use of simple ELISAs. Here, NXPH4 is linked to hepatocellular carcinoma.